AKERO THERAPEUTICS INC

CUSIP: 00973Y108 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 99,917 Value ($000) $4,744 Avg Close — Range —
Q2 2025
Shares 161,565 Value ($000) $8,621 Avg Close — Range —
Q1 2025
Shares 109,909 Value ($000) $4,449 Avg Close — Range —
Q4 2024
Shares 71,451 Value ($000) $1,988 Avg Close — Range —
Q3 2024
Shares 60,416 Value ($000) $1,733 Avg Close — Range —
Q2 2024
Shares 65,614 Value ($000) $1,539 Avg Close — Range —
Q1 2024
Shares 46,539 Value ($000) $1,176 Avg Close — Range —
Q4 2023
Shares 46,539 Value ($000) $1,087 Avg Close — Range —
Q3 2023
Shares 46,539 Value ($000) $2,354 Avg Close — Range —
Q2 2023
Shares 38,090 Value ($000) $1,457 Avg Close — Range —
Q1 2023
Shares 38,090 Value ($000) $1,457 Avg Close — Range —
Q4 2022
Shares 35,969 Value ($000) $1,971 Avg Close — Range —
Q3 2022
Shares 24,609 Value ($000) $837,937 Avg Close — Range —
Q2 2022
Shares 33,872 Value ($000) $320,090 Avg Close — Range —
Q1 2022
Shares 18,640 Value ($000) $264,502 Avg Close — Range —
Q1 2021
Shares 7,300 Value ($000) $211,773 Avg Close — Range —
Q4 2020
Shares 8,400 Value ($000) $216,720 Avg Close — Range —
Q3 2020
Shares 8,400 Value ($000) $258,636 Avg Close — Range —